SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+0.17%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$233M
AUM Growth
+$233M
(+9.4%)
Cap. Flow
+$21.4M
Cap. Flow
% of AUM
9.18%
Top 10 Holdings %
Top 10 Hldgs %
39.53%
Holding
45
New
6
Increased
12
Reduced
9
Closed
5
Top Buys
| 1 |
Merck
MRK
|
$7.98M |
| 2 |
AbbVie
ABBV
|
$6.38M |
| 3 |
Medtronic
MDT
|
$5.44M |
| 4 |
Humana
HUM
|
$4.61M |
| 5 |
UnitedHealth
UNH
|
$4.49M |
Top Sells
| 1 |
Stryker
SYK
|
$2.85M |
| 2 |
Revvity
RVTY
|
$2.8M |
| 3 |
Globus Medical
GMED
|
$2.8M |
| 4 |
Johnson & Johnson
JNJ
|
$2.65M |
| 5 |
Moderna
MRNA
|
$2.34M |
Sector Composition
| 1 | Healthcare | 93.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $15.2M | 6.55% |
200,000
+25,000
| +14% | +$1.91M |
|
|
2
Humana
HUM
$36.5B
| $10.9M | 4.7% |
22,500
+9,500
| +73% | +$4.61M |
|
3
Novo Nordisk
NVO
$251B
| $9.55M | 4.1% |
60,000
+10,000
| +20% | +$1.59M |
|
4
Tenet Healthcare
THC
$16.3B
| $8.91M | 3.83% |
150,000
-15,000
| -9% | -$891K |
|
|
5
UnitedHealth
UNH
$281B
| $8.27M | 3.56% |
17,500
+9,500
| +119% | +$4.49M |
|
|
6
Merck
MRK
$210B
| $7.98M | 3.43% |
+75,000
| New | +$7.98M |
|
7
HCA Healthcare
HCA
$94.5B
| $7.91M | 3.4% |
30,000
-5,000
| -14% | -$1.32M |
|
8
Boston Scientific
BSX
$156B
| $7.76M | 3.33% |
155,000
-30,000
| -16% | -$1.5M |
|
9
Zimmer Biomet
ZBH
$21B
| $7.75M | 3.33% |
60,000
| – | – |
|
10
Intuitive Surgical
ISRG
$170B
| $7.66M | 3.29% |
30,000
| – | – |
|
|
11
Stryker
SYK
$150B
| $7.14M | 3.07% |
25,000
-10,000
| -29% | -$2.85M |
|
12
Universal Health Services
UHS
$11.6B
| $6.99M | 3% |
54,990
-10
| -0% | -$1.27K |
|
13
Eli Lilly
LLY
$657B
| $6.87M | 2.95% |
20,000
+2,500
| +14% | +$859K |
|
14
Cencora
COR
$56.5B
| $6.4M | 2.75% |
40,000
+10,000
| +33% | +$1.6M |
|
|
15
AbbVie
ABBV
$372B
| $6.38M | 2.74% |
+40,000
| New | +$6.38M |
|
16
Thermo Fisher Scientific
TMO
$186B
| $6.34M | 2.73% |
11,000
| – | – |
|
17
Baxter International
BAX
$12.7B
| $6.08M | 2.62% |
150,000
| – | – |
|
18
Cardinal Health
CAH
$35.5B
| $6.04M | 2.6% |
80,000
+10,000
| +14% | +$755K |
|
19
Surgery Partners
SGRY
$2.91B
| $6.03M | 2.59% |
175,000
+10,000
| +6% | +$345K |
|
20
Agilent Technologies
A
$35.7B
| $5.53M | 2.38% |
40,000
| – | – |
|
|
21
Medtronic
MDT
$119B
| $5.44M | 2.34% |
+67,500
| New | +$5.44M |
|
22
McKesson
MCK
$85.4B
| $5.34M | 2.3% |
15,000
| – | – |
|
23
Acadia Healthcare
ACHC
$2.12B
| $5.06M | 2.17% |
70,000
| – | – |
|
24
Danaher
DHR
$147B
| $5.04M | 2.17% |
20,000
| – | – |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.86M | 2.09% |
50,000
-10,000
| -17% | -$972K |
|